Ionis Pharmaceuticals
IONS
204 hedge funds and large institutions have $3.91B invested in Ionis Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 61 increasing their positions, 75 reducing their positions, and 13 closing their positions.
254% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 13
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
38% more capital invested
Capital invested by funds: $2.84B → $3.91B (+$1.07B)
18% more funds holding
Funds holding: 173 → 204 (+31)
19% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 75
31% less call options, than puts
Call options by funds: $40.4M | Put options by funds: $58.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$43.9M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$27.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.9M |
| 4 |
PC
PointState Capital
New York
|
+$21.7M |
| 5 |
CCI
Columbus Circle Investors
|
+$20M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$29.9M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$21.8M |
| 3 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$16.9M |
| 4 |
Millennium Management
New York
|
-$16.6M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$13M |
IONS Hedge Fund Activity: Q3 2013 in Review
204 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q3 2013, worth a combined $3.91B — up 38% from $2.84B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new IONS positions and 13 closed out — a net gain of 33 holders — while 61 added to existing stakes and 75 trimmed.
The largest buyer was Artisan Partners, adding an estimated $43.9M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $29.9M.
- 204 institutional investors held Ionis Pharmaceuticals (IONS) as of Q3 2013, up from 173 in Q2 2013.
- Funds reported $3.91B of Ionis Pharmaceuticals stock for Q3 2013, up 38% quarter-over-quarter.
- 46 funds opened new Ionis Pharmaceuticals positions in Q3 2013 and 13 closed out, a net change of +33 holders.
- The largest Ionis Pharmaceuticals buyer in Q3 2013 was Artisan Partners, an estimated $43.9M added.
- The largest Ionis Pharmaceuticals seller in Q3 2013 was BNP Paribas Financial Markets, an estimated $29.9M sold.
Based on aggregated 13F filings for Q3 2013.